Home›Search›PharmacoEconomics - Open

PharmacoEconomics - Open

Springer International Publishing · Switzerland · Est. 2011

ISSN2509-4262eISSN2509-4254

SJR Q2✓ WOS ESCI✓ Scopus / SJR✓ DOAJ✓ Open Access

/ 100

Medium Risk

Score Breakdown

✓ WoS ESCI+10

✓ Scopus Q2+18

✓ DOAJ Verified+15

Total53

Journal Impact Factor

This journal is indexed in Web of Science (JCR) and has an official Journal Impact Factor. View the current value on the journal’s page ↗

SJR Score

0.809

H-Index

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIP

0.827

Total Works

642

Total Citations

6,521

2yr Mean Citedness

2.39

Free JIF alternative

Aims & Scope✦ Inferred from recent articles

This journal publishes research on the economic evaluation of healthcare interventions, including cost-effectiveness analyses, cost-utility analyses, and burden-of-disease studies. It focuses on quantifying the costs and outcomes associated with various medical conditions, treatments, and screening programs. The research often involves modeling, systematic reviews, and real-world data analysis to inform healthcare decision-making.

AI-summarised from recent articles · verify on publisher page →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

weeks to review

Fast · median is 15 wks

SJR Rank

Top 50% in field

General Information

Country / RegionSwitzerland

Primary LanguageEnglish

1st Year Published2011

Annual Volume~ 81 articles / year

StatusActive (last: 2026)

Total Publications642

Publisher OrgAdis, Springer Healthcare

OA Since2016

Visit Journal Website

Submission Info

Peer ReviewSingle-blind

Review Time~8 weeks

Acceptance Rate—

OA LicenseCC BY-NC

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

📦 Long-term Preservation

PorticoPMCCLOCKSS

Think.Check.Submit Compliance

thinkchecksubmit.org

10/12 · 83%

✅

Do you know the journal / publisher?

Springer International Publishing

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2509-4262 / 2509-4254

✅

Indexed in a trusted database?

Scopus, DOAJ

✅

Peer review process documented?

Single-blind

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

Portico, PMC, CLOCKSS

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Times cited

2019

2020

2021

2022

2023

2024

2025

2026

Source: OpenAlex · Note: citations accumulate over time so older years appear higher

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Health PolicyQ2

PharmacologyQ2

Pharmacology (medical)Q2

Subject Classification

Web of Science Categories

EconomicsHealth Care Sciences & ServicesHealth Policy & ServicesPharmacology & Pharmacy

Scopus Categories

PharmacologyPharmacology (medical)Health Policy

Research Topics (OpenAlex)

Health Systems, Economic Evaluations, Quality of LifeEconomic and Financial Impacts of CancerPharmaceutical Economics and PolicyEconomic and Environmental ValuationHealthcare Policy and ManagementMultiple Sclerosis Research StudiesMedication Adherence and ComplianceCancer Immunotherapy and BiomarkersHealthcare Systems and ReformsLung Cancer Treatments and Mutations